List view / Grid view
31 January 2011 | By Novartis
The FDA approval of Menveo for use in children 2 to 10 years of age is based on Phase III trial data involving 5,297 participants in that age group...
31 January 2011 | By Roche
Roche announced that the U.S. FDA approved Rituxan/MabThera as a maintenance treatment for patients with advanced follicular lymphoma...
28 January 2011 | By Bayer HealthCare
Bayer HealthCare and Zydus Cadila signed today an agreement in Mumbai, India, to form the Joint Venture Company Bayer Zydus Pharma...
Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its new informatics offerings within booth #2835 at PITTCON 2011, being held from March 13-18 at the Georgia World Congress Center in Atlanta.
27 January 2011 | By kdm communications limited
New 25 ml trough is designed to reduce waste of valuable reagents in automated liquid handling applications...
26 January 2011 | By BioFocus
BioFocus has signed a 3 year compound management services agreement with Lundbeck Research USA...
25 January 2011 | By Edelman
First to combine optical label-free technology & traditional labeled assays to accurately identify potential new therapeutic targets...
25 January 2011 | By Novo Nordisk
EMD Millipore, announced an agreement with Novo Nordisk, to transfer the distribution of recombinant human insulin for cell culture media...
25 January 2011 | By kdm communications limited
An advanced system for optimized washing of cells, beads and ELISAs in 96- and 384-well formats...
24 January 2011 | By Amgen
Amgen announced that the companies have entered into a definitive acquisition agreement under which Amgen is to acquire BioVex Group...
24 January 2011 | By GlaxoSmithKline
GlaxoSmithKline announced the start of two global Phase III studies in advanced or metastatic melanoma patients with a BRAF V600 mutation...
24 January 2011 | By Novartis
Novartis announced today that it has entered into a definitive agreement for the acquisition of Genoptix, Inc...
24 January 2011 | By Novartis
Swissmedic and TGA have granted approval for Gilenya® (fingolimod)...
21 January 2011 | By AstraZeneca
AstraZeneca announced it has replied to the US FDA Complete Response Letter received for the ticagrelor (BRILINTA) New Drug Application...
20 January 2011 | By Brands2Life
Cognizant, announced that it has been selected by Eli Lilly and Company...
